1100 results
-
List item
News: EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep (updated)
CHMP, Last updated: 28/09/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 September 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 11/09/2023 to 14/09/2023, Last updated: 14/09/2023 -
List item
News: Revocation of authorisation for sickle cell disease medicine Adakveo
CHMP, Last updated: 09/08/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-26 April 2023
European Medicines Agency, Amsterdam, the Netherlands, from 24/04/2023 to 26/04/2023, Last updated: 07/07/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24 - 26 April 2023
CHMP, Last updated: 26/05/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 27-30 March 2023
European Medicines Agency, Amsterdam, the Netherlands, from 27/03/2023 to 30/03/2023, Last updated: 22/05/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 22-25 May 2023
European Medicines Agency, Amsterdam, the Netherlands, from 22/05/2023 to 25/05/2023, Last updated: 22/05/2023 -
List item
Committee for Herbal Medicinal Products (HMPC): 10-12 May 2023
European Medicines Agency, Amsterdam, the Netherlands, from 10/05/2023 to 12/05/2023, Last updated: 10/05/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 February 2023
European Medicines Agency, Amsterdam, the Netherlands, from 20/02/2023 to 23/02/2023, Last updated: 24/04/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 January 2023
European Medicines Agency, Amsterdam, the Netherlands, from 23/01/2023 to 26/01/2023, Last updated: 14/04/2023 -
List item
News: EU recommendations for 2023-2024 seasonal flu vaccine composition
CHMP, Last updated: 04/04/2023 -
List item
Committee for Herbal Medicinal Products (HMPC): 21-23 November 2022
from 21/11/2022 to 23/11/2022, Last updated: 31/01/2023 -
List item
News: EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
CHMP, Last updated: 13/01/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 7-10 November 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/11/2022 to 10/11/2022, Last updated: 10/01/2023 -
List item
Committee for Herbal Medicinal Products (HMPC): 29-31 January 2024
from 29/01/2024 to 31/01/2024, Last updated: 08/12/2022 -
List item
Committee for Herbal Medicinal Products (HMPC): 18-20 March 2024
from 18/03/2024 to 20/03/2024, Last updated: 08/12/2022 -
List item
Committee for Herbal Medicinal Products (HMPC): 27-29 May 2024
from 27/05/2024 to 29/05/2024, Last updated: 08/12/2022 -
List item
Committee for Herbal Medicinal Products (HMPC): 22-24 July 2024
from 22/07/2024 to 24/07/2024, Last updated: 08/12/2022 -
List item
Committee for Herbal Medicinal Products (HMPC): 23-25 September 2024
from 23/09/2024 to 25/09/2024, Last updated: 08/12/2022 -
List item
Committee for Herbal Medicinal Products (HMPC): 18-20 November 2024
from 18/11/2024 to 20/11/2024, Last updated: 08/12/2022 -
List item
Committee for Herbal Medicinal Products (HMPC): 19-21 September 2022
from 19/09/2022 to 21/09/2022, Last updated: 02/12/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 10-13 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/10/2022 to 13/10/2022, Last updated: 23/11/2022 -
List item
News: EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine
CHMP, Last updated: 11/11/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 August 2022
Written procedure, from 16/08/2022 to 19/08/2022, Last updated: 04/10/2022 -
List item
Committee for Herbal Medicinal Products (HMPC): 18-20 July 2022
from 18/07/2022 to 20/07/2022, Last updated: 23/09/2022